BioPharmGuy

Been a minute since I’ve had to apply for a job, so I knew the landscape would have changed since 2008. However, I got an email this week from someone seeking help for an upcoming job interview. This individual was assigned a case study project that was really specific and actionable…almost as if the company was using interviewees to do unpaid work. Very, very uncool, but maybe this is normal nowadays? Hope not.

On that careers note, our friends at BioCentriq are looking for a new Director of Business Development and hopefully they won’t make you do unpaid consulting work as your interview. They do contract manufacturing and development out of New Jersey. They’re hoping for someone with 10 years experience in cell & gene therapy, but considering how new that field is, maybe they’ll give you a look with slightly less than that.

Finally, as a longtime Detroit Lions fan, I'm torn on who to root for this Super Bowl Sunday (though it should be on Saturday and that's a whole different rant). On the one hand, the Lions QB left this year and is now in the Super Bowl, and he's a good dude. On the other hand, two years ago the Bengals were a very Lions-like 2-14 and for them to win it all so quickly after being trash would bring me much hope. This decision would have been a lot easier if my former schoolmate Tom Brady were in the game...

-BPG

January Company Funding
With the public markets shriveling up, the IPO window duly slammed shut. Only four this month for $486M.

Private rounds were largely immune to market turmoil. 52 companies were funded to the tune of $6.4B, though admittedly, that's a little misleading. One company raked in $3B for the most mind-boggling cash avalanche in biotech, probably ever.

Summary file available on our downloads page.

Companies Added & Removed
We added 18 companies and removed 19 this week. 

Best new name:
Robocath

You won't be missed:
Lisa Cryobanking

Best reason for removal:
"Seems to have been a shell to transfer pain asset"

Summary file available on our downloads page.